Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 16/11/21 → 15/11/23 |
Funding
- Non-EU industry, commerce and public corporations: £398,679.00
Integrated injectable hydrogel and metal organic framework nanomedicine (Hy-MOFN) for safe and effective cancer treatment (£398,679.00)
- Chen, Michael (Principal Investigator)
- Huang, Harvey (Principal Investigator)